Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Center, University of Copenhagen, Copenhagen N, Denmark.
Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Center, University of Copenhagen, Copenhagen N, Denmark.
J Biol Chem. 2020 Jul 3;295(27):9157-9170. doi: 10.1074/jbc.RA120.013710. Epub 2020 May 18.
C-type lectins that contain collagen-like domains are known as collectins. These proteins are present both in the circulation and in extravascular compartments and are central players of the innate immune system, contributing to first-line defenses against viral, bacterial, and fungal pathogens. The collectins mannose-binding lectin (MBL) and surfactant protein D (SP-D) are regulated by tissue fibroblasts at extravascular sites via an endocytic mechanism governed by urokinase plasminogen activator receptor-associated protein (uPARAP or Endo180), which is also a collagen receptor. Here, we investigated the molecular mechanisms that drive the uPARAP-mediated cellular uptake of MBL and SP-D. We found that the uptake depends on residues within a protruding loop in the fibronectin type-II (FNII) domain of uPARAP that are also critical for collagen uptake. Importantly, however, we also identified FNII domain residues having an exclusive role in collectin uptake. We noted that these residues are absent in the related collagen receptor, the mannose receptor (MR or CD206), which consistently does not interact with collectins. We also show that the second C-type lectin-like domain (CTLD2) is critical for the uptake of SP-D, but not MBL, indicating an additional level of complexity in the interactions between collectins and uPARAP. Finally, we demonstrate that the same molecular mechanisms enable uPARAP to engage MBL immobilized on the surface of pathogens, thereby expanding the potential biological implications of this interaction. Our study reveals molecular details of the receptor-mediated cellular regulation of collectins and offers critical clues for future investigations into collectin biology and pathology.
C 型凝集素包含胶原样结构域,被称为凝集素。这些蛋白存在于血液循环和血管外间隙中,是先天免疫系统的核心成员,有助于对抗病毒、细菌和真菌病原体的第一道防线。凝集素甘露糖结合凝集素(MBL)和表面活性剂蛋白 D(SP-D)在血管外部位通过尿激酶纤溶酶原激活物受体相关蛋白(uPARAP 或 Endo180)介导的内吞机制由组织成纤维细胞调节,uPARAP 也是胶原受体。在这里,我们研究了驱动 uPARAP 介导的 MBL 和 SP-D 细胞摄取的分子机制。我们发现摄取依赖于 uPARAP 纤维连接蛋白 II 型(FNII)结构域中突出环内的残基,这些残基对于胶原摄取也是至关重要的。然而,重要的是,我们还确定了 FNII 结构域中在凝集素摄取中具有独特作用的残基。我们注意到,这些残基在相关胶原受体甘露糖受体(MR 或 CD206)中不存在,MR 或 CD206 始终不与凝集素相互作用。我们还表明,第二个 C 型凝集素样结构域(CTLD2)对于 SP-D 的摄取至关重要,但对 MBL 摄取不重要,这表明凝集素和 uPARAP 之间的相互作用具有更高的复杂性。最后,我们证明相同的分子机制使 uPARAP 能够与固定在病原体表面的 MBL 结合,从而扩大了这种相互作用的潜在生物学意义。我们的研究揭示了受体介导的凝集素细胞调节的分子细节,并为未来的凝集素生物学和病理学研究提供了关键线索。